戻る Agenda
CBER Town Hall
Session Chair(s)
Karen Midthun, MD
Principal, Drug and Biological Products
Greenleaf Health, United States
This forum will provide an overview of CBER's current work on ongoing initiatives, guidances, and regulations.
Learning Objective : Summarize key issues discussed by CBER; Identify regulatory hot topics in biologics.
Speaker(s)
Panelist
Robert A. Yetter, PHD
FDA, United States
Associate Director for Review Management, Office of the Director, CBER